scispace - formally typeset
B

Belén Gutiérrez-Gutiérrez

Researcher at University of Seville

Publications -  56
Citations -  2263

Belén Gutiérrez-Gutiérrez is an academic researcher from University of Seville. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 17, co-authored 44 publications receiving 1428 citations. Previous affiliations of Belén Gutiérrez-Gutiérrez include Spanish National Research Council & Carlos III Health Institute.

Papers
More filters
Journal ArticleDOI

Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.

TL;DR: Overall, therapy of MDR-E infection must be individualized according to the susceptibility profile, type, and severity of infection and the features of the patient.
Journal ArticleDOI

Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study

Belén Gutiérrez-Gutiérrez, +93 more
TL;DR: Patients with BSIs due to CPE should receive active therapy as soon as they are diagnosed, and monotherapy should be considered for those in the low-mortality-score stratum.
Journal ArticleDOI

Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain.

Juan Berenguer, +562 more
TL;DR: The findings provide comprehensive information about characteristics and complications of severe COVID-19 and may help to identify patients at a higher risk of death.
Journal ArticleDOI

Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations

TL;DR: It is important to characterize the isolate's phenotypic and genotypic resistance profile, and to receive an empirical treatment which includes active antibiotics, and directed therapy should be adjusted according to susceptibility study results and the severity of the infection.